New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:59 EDTISRG, NVDQ, SYKIntuitive Surgical climbs after new surgical system debuts
Shares of surgical instrument and accessory maker Intuitive Surgical (ISRG) are climbing after the company announced the FDA cleared the U.S introduction of its new da Vinci Xi Surgical System. WHAT'S NEW: Intuitive Surgical introduced the da Vinci Xi Surgical System, which it says has broader capabilities than prior generations of its prior generation da Vinci System. Intuitive said it designed the new da Vinci Xi System with the goal of further advancing the technology used in minimally invasive surgery for complex diseases and conditions in gynecology, urology, thoracic, cardiac, and general surgery. ANALYST OPINON: Research firm Leerink sees today's news as a positive for Intuitive Surgical, but said it is uncertain exactly how many incremental system sales the da Vinci XI Surgical system will fuel and whether the features of Intuitive's new robot will lead to increased utilization into new surgery areas. The firm keeps the stock at a Market Perform rating. JPMorgan responded to the news by raising its price target on Intuitive Surgical to $500 from $475. JPMorgan said it views the new system as a significant positive that has the potential to both drive a replacement cycle and further increase penetration and utilization of the company's products within hospitals. PRICE ACTION: Near midday, shares of Intuitive Surgical were up about $39, or 8.9%, to $477. OTHERS TO WATCH: Novadaq (NVDQ), which sells consoles for Intuitive Surgical's robotic systems, rose 2.2% to $22.77. Shares of Stryker (SYK), which previously acquired robotic surgery systems maker MAKO Surgical, were little changed near noon.
News For ISRG;NVDQ;SYK From The Last 14 Days
Check below for free stories on ISRG;NVDQ;SYK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 12, 2014
10:00 EDTSYKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:22 EDTSYKStryker upgraded to Buy from Hold at Needham
Subscribe for More Information
August 11, 2014
11:35 EDTNVDQNovadaq management to meet with JMP Securities
Subscribe for More Information
August 7, 2014
13:24 EDTSYKStryker upcoming analyst day may be catalyst for shares, says Argus
Argus believes Stryker is well positioned to post stronger sales and earnings in the second half of the year as new products launch and surgical volume rebounds. The firm thinks the company's analyst day on September 17 could be a catalyst for the shares and it maintains its Buy rating and $102 price target on the stock.
August 6, 2014
07:32 EDTNVDQNovadaq revenue growth could accelerate, says Stifel
Subscribe for More Information
07:20 EDTNVDQNovadaq shares should be bought after miss, says JMP Securities
After Novadaq reported weaker than expected Q2 results, JMP Securities is encouraged by the company's focus on clinical trials and remains upbeat about the clinical value of its SPY fluorescence technology. Consequently, the firm continues to recommend buying the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use